-
SLS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
SELLAS Life Sciences (SLS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 21.13 mm | 21.13 mm | 21.13 mm | 21.13 mm | 21.13 mm | 21.13 mm |
Cash burn (monthly) | (no burn) | (no burn) | 2.44 mm | 2.73 mm | 2.60 mm | 2.76 mm |
Cash used (since last report) | n/a | n/a | 9.85 mm | 11.01 mm | 10.49 mm | 11.11 mm |
Cash remaining | n/a | n/a | 11.29 mm | 10.13 mm | 10.64 mm | 10.02 mm |
Runway (months of cash) | n/a | n/a | 4.6 | 3.7 | 4.1 | 3.6 |
13F holders | Current |
---|---|
Total holders | 30 |
Opened positions | 9 |
Closed positions | 15 |
Increased positions | 8 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 6.17 bn |
Total shares | 19.55 mm |
Total puts | 0.00 |
Total calls | 16.90 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Highbridge Capital Management | 13.26 mm | $15.79 mm |
Vanguard | 2.29 mm | $2.87 bn |
Anson Funds Management | 793.84 k | $992.29 mm |
Equilibria Capital Management | 643.26 k | $37.63 mm |
Geode Capital Management | 605.19 k | $756.58 mm |
BlackRock | 431.62 k | $539.52 mm |
CVI Investments | 315.25 k | $1.83 mm |
Opus Capital | 226.10 k | $283.00 k |
Hirschman Orin | 190.00 k | $1.59 mm |
STT State Street | 174.53 k | $218.16 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jan 25 | Katherine Bach Kalin | Common Stock | Grant | Acquire A | No | No | 0 | 12,500 | 0.00 | 21,000 |
10 Jan 25 | Katherine Bach Kalin | Stock Option Common Stock | Grant | Acquire A | No | No | 0.9525 | 18,500 | 17.62 k | 18,500 |
10 Jan 25 | Burns John Thomas | Common Stock | Grant | Acquire A | No | No | 0 | 81,300 | 0.00 | 299,062 |
10 Jan 25 | Burns John Thomas | Common Stock | Grant | Acquire A | No | No | 0 | 113,000 | 0.00 | 217,762 |
10 Jan 25 | Burns John Thomas | Stock Option Common Stock | Grant | Acquire A | No | No | 0.9525 | 169,500 | 161.45 k | 169,500 |
10 Jan 25 | Scheinberg David A | Common Stock | Grant | Acquire A | No | No | 0 | 12,500 | 0.00 | 23,082 |
10 Jan 25 | Scheinberg David A | Stock Option Common Stock | Grant | Acquire A | No | No | 0.9525 | 18,500 | 17.62 k | 18,500 |
10 Jan 25 | Wasman Jane | Common Stock | Grant | Acquire A | No | No | 0 | 12,500 | 0.00 | 22,900 |
10 Jan 25 | Wasman Jane | Stock Option Common Stock | Grant | Acquire A | No | No | 0.9525 | 18,500 | 17.62 k | 18,500 |
10 Jan 25 | Stergiou Angelos M. | Common Stock | Grant | Acquire A | No | No | 0 | 243,900 | 0.00 | 859,032 |